News >

Neoadjuvant Immunotherapy Plus Radiation Shows Promise in Soft Tissue Sarcoma

Jessica Hergert
Published: Tuesday, Oct 22, 2019

Vincent Y. Ng, MD, an assistant professor of orthopedics at the University of Maryland Medical Center

Vincent Y. Ng, MD

The use of neoadjuvant durvalumab (Imfinzi) and tremelimumab plus radiation appears to show an improved radiologic and histologic response for patients with high-risk soft tissue sarcoma, according to preliminary results of the phase I/II NEXIS trial (NCT03116529), said Vincent Y. Ng, MD. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication